SOPHARMA (SPH) komunikat - current report 4 inf. za kfn12.2012 ENG

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		4	/	2013
Date of issue:	2013-01-10
Short name of the issuer
SOPHARMA AD
Subject
current report 4 inf. za kfn12.2012 ENG
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
The Board of Directors of Sopharma AD (the “Company") notifies that for December 2012 Sopharma AD realized decrease of sales revenues of 13% compared to the same period of 2011, including 9% decrease of domestic sales and 17% decrease of export sales. During the past twelve months Sopharma AD recorded an increase of sales revenues of 0.35%, including 9% decrease of domestic sales and 5% increase of export sales compared to 2011.
Annexes
File			Description
current report 4 inf. za kfn12.2012 ENG.doc			current report 4 inf. za kfn12.2012 ENG

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2013-01-10	Ognian Donev	Executive Director

Konta:	Konta osobiste Konta młodzieżowe Konta firmowe Konta walutowe
Kredyty:	Kredyty gotówkowe Kredyty mieszkaniowe Kredyty z dopłatą Kredyty dla firm

current report 4 inf. za kfn12.2012 ENG